These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 22006031)

  • 21. [CT-guided radiofrequency ablation of liver metastases from colorectal cancer].
    Mahnken AH; Bruners P; Tacke JA; Günther RW
    Dtsch Med Wochenschr; 2009 May; 134(19):976-80. PubMed ID: 19401962
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Percutaneous ablation of renal masses measuring 3.0 cm and smaller: comparative local control and complications after radiofrequency ablation and cryoablation.
    Atwell TD; Schmit GD; Boorjian SA; Mandrekar J; Kurup AN; Weisbrod AJ; Chow GK; Leibovich BC; Callstrom MR; Patterson DE; Lohse CM; Thompson RH
    AJR Am J Roentgenol; 2013 Feb; 200(2):461-6. PubMed ID: 23345372
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Stereotactic Radiofrequency Ablation (SRFA) of intrahepatic cholangiocellular carcinomas: a minimal invasive alternative to liver resection].
    Bale R; Schullian P; Haidu M; Widmann G
    Wien Med Wochenschr; 2013 Mar; 163(5-6):128-31. PubMed ID: 23392811
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Percutaneous saline-enhanced radiofrequency ablation of unresectable hepatic tumors: initial experience in 26 patients.
    Kettenbach J; Köstler W; Rücklinger E; Gustorff B; Hüpfl M; Wolf F; Peer K; Weigner M; Lammer J; Müller W; Goldberg SN
    AJR Am J Roentgenol; 2003 Jun; 180(6):1537-45. PubMed ID: 12760914
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Prognosis and risk factors for recurrence of small liver cancer after a single session of percutaneous radiofrequency ablation].
    Xia JL; Ye SL; Zou JH; Ren ZG; Gan YH; Wang YH; Chen Y; Ge NL; Tang ZY; Yang BH
    Ai Zheng; 2004 Sep; 23(9):977-80. PubMed ID: 15363186
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Single-session combined therapy with chemoembolization and radiofrequency ablation in hepatocellular carcinoma less than or equal to 5 cm: a preliminary study.
    Kang SG; Yoon CJ; Jeong SH; Kim JW; Lee SH; Lee KH; Kim YH
    J Vasc Interv Radiol; 2009 Dec; 20(12):1570-7. PubMed ID: 19879777
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radiofrequency ablation of colorectal liver metastases: small size favorably predicts technique effectiveness and survival.
    Veltri A; Sacchetto P; Tosetti I; Pagano E; Fava C; Gandini G
    Cardiovasc Intervent Radiol; 2008; 31(5):948-56. PubMed ID: 18506519
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety and efficacy of stereotactic radiofrequency ablation for very large (≥8 cm) primary and metastatic liver tumors.
    Schullian P; Johnston EW; Putzer D; Eberle G; Laimer G; Bale R
    Sci Rep; 2020 Jan; 10(1):1618. PubMed ID: 32005871
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combined therapies for the treatment of technically unresectable liver malignancies: bland embolization and radiofrequency thermal ablation within the same session.
    Bonomo G; Della Vigna P; Monfardini L; Orgera G; Chiappa A; Bianchi PP; Zampino MG; Orsi F
    Cardiovasc Intervent Radiol; 2012 Dec; 35(6):1372-9. PubMed ID: 22271077
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Microwave ablation of liver metastases guided by contrast-enhanced ultrasound: experience with 125 metastases in 39 patients.
    Lorentzen T; Skjoldbye BO; Nolsoe CP
    Ultraschall Med; 2011 Oct; 32(5):492-6. PubMed ID: 21259183
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prospective study of a 'popping' sound during percutaneous radiofrequency ablation for hepatocellular carcinoma.
    Fernandes ML; Lin CC; Lin CJ; Chen WT; Lin SM
    J Vasc Interv Radiol; 2010 Feb; 21(2):237-44. PubMed ID: 20031448
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Extending indications for radiofrequency ablation of lung tumors through an intraoperative approach.
    Linden PA; Wee JO; Jaklitsch MT; Colson YL
    Ann Thorac Surg; 2008 Feb; 85(2):420-3. PubMed ID: 18222236
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recurrence-free survival after radiofrequency ablation of hepatocellular carcinoma. A registry report of the impact of risk factors on outcome.
    Zytoon AA; Ishii H; Murakami K; El-Kholy MR; Furuse J; El-Dorry A; El-Malah A
    Jpn J Clin Oncol; 2007 Sep; 37(9):658-72. PubMed ID: 17766723
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radiofrequency ablation as first-line treatment for small solitary hepatocellular carcinoma: long-term results.
    Peng ZW; Zhang YJ; Chen MS; Lin XJ; Liang HH; Shi M
    Eur J Surg Oncol; 2010 Nov; 36(11):1054-60. PubMed ID: 20846819
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Percutaneous radiofrequency ablation with transarterial embolization is useful for treatment of stage 1 renal cell carcinoma with surgical risk: results at 2-year mean follow up.
    Arima K; Yamakado K; Kinbara H; Nakatsuka A; Takeda K; Sugimura Y
    Int J Urol; 2007 Jul; 14(7):585-90; discussion 590. PubMed ID: 17645597
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Radiofrequency ablation of hepatocellular carcinoma: long-term experience with expandable needle electrodes.
    Cabassa P; Donato F; Simeone F; Grazioli L; Romanini L
    AJR Am J Roentgenol; 2006 May; 186(5 Suppl):S316-21. PubMed ID: 16632694
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radiofrequency ablation of intrahepatic cholangiocarcinoma: preliminary experience.
    Carrafiello G; Laganà D; Cotta E; Mangini M; Fontana F; Bandiera F; Fugazzola C
    Cardiovasc Intervent Radiol; 2010 Aug; 33(4):835-9. PubMed ID: 20411389
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Percutaneous radiofrequency ablation of liver tumors using multiple saline-perfused electrodes.
    Hänsler J; Frieser M; Tietz V; Uhlke D; Wissniowski T; Bernatik T; Hothorn T; Hahn EG; Strobel D
    J Vasc Interv Radiol; 2007 Mar; 18(3):405-10. PubMed ID: 17377187
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stereotactic radiofrequency ablation.
    Bale R; Widmann G; Haidu M
    Cardiovasc Intervent Radiol; 2011 Aug; 34(4):852-6. PubMed ID: 20734193
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thermal ablation of intrahepatic cholangiocarcinoma: Safety, efficacy, and factors affecting local tumor progression.
    Takahashi EA; Kinsman KA; Schmit GD; Atwell TD; Schmitz JJ; Welch BT; Callstrom MR; Geske JR; Kurup AN
    Abdom Radiol (NY); 2018 Dec; 43(12):3487-3492. PubMed ID: 29869103
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.